IFITM1 Antibody (R30277)

IFITM1 Antibody Human Cancer Cell and Immune Cell WB. Western blot analysis was performed using IFITM1 Antibody on lane 1: human SW620 colon cancer cell lysate and lane 2: human CEM T lymphoblast cell lysate. A distinct immunoreactive band is detected at approximately 15 kDa in both samples, consistent with the expected molecular weight of IFITM1. Detection in both epithelial cancer and immune-derived cells demonstrates expression of this interferon-responsive membrane protein across diverse cellular models. This IFITM1 Antibody / Interferon Induced Transmembrane Protein Antibody is well suited for Western blot studies of interferon signaling, innate immunity, antiviral defense, and immune cell biology.

IFITM1 Antibody Human Intestinal Cancer IHC. IFITM1 Antibody was used for immunohistochemical staining of FFPE human intestinal cancer tissue. Following heat-induced epitope retrieval, the tissue was incubated with the primary antibody, followed by an HRP-conjugated secondary antibody and DAB chromogen for visualization. Distinct membranous and cytoplasmic staining is observed in tumor-associated cells, consistent with the localization of the interferon-induced transmembrane protein IFITM1. This IFITM1 Antibody / Interferon Induced Transmembrane Protein Antibody is well suited for investigating interferon signaling, innate immune responses, antiviral defense mechanisms, and the role of IFITM1 in tumor progression and immune regulation.